InveniAI
Business Services · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2614 Boston Post Rd Ste 33B, Guilford, C...Phone Number
(203) 643-8002Website
www.inveniai.comRevenue
$7.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About InveniAI
InveniAI is a global leader in applying artificial intelligence and machine learning to accelerate drug discovery and development for diseases with unmet medical needs. Their technology platform, AlphaMeld, integrates complex scientific data to enable rapid identification and prioritization of transformative therapies. The company focuses on addressing chronic inflammatory diseases of the gut, aiming to maximize localized efficacy while minimizing systemic side effects. InveniAI collaborates with various partners to innovate and enhance patient solutions at unprecedented scale and speed.Explore more
InveniAI Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InveniAI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when InveniAI launches new products
Check if InveniAI has recently received funding, and reach out quickly before it becomes old news!
Check out if InveniAI is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once InveniAI has new funding data
Earning: See what the market has to say on InveniAI recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
InveniAI, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at InveniAI
Click to see if InveniAI had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at InveniAI
Find more new buyers
Compare Similar Companies to InveniAI
Compare insights from companies similar to InveniAI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InveniAI is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
InveniAI is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about InveniAI.
InveniAI Tech Stack
A closer look at the technologies used by InveniAI
InveniAI News & Media
Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets
OSAKA, Japan, Feb. 20, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it has entered into a research collaboration agreement with InveniAI® LLC (Guilford, Connecticut, USA; President and CEO: Krishnan Nandabalan;...InveniAI's AlphaMeld Platform Debuts the Addition of ChatAlphaMeld™, A Powerful Tool Designed to Scale Target and Drug Discovery and Development
Powered by GPT-4, ChatAlphaMeld enables user interaction across functional stakeholders to automate hypothesis generation and prioritization Integrated into the AlphaMeld workflow, ChatAlphaMeld is trained for and can query biopharma R&D workflows only GUILFORD, Conn., April 04, 2023 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader in leveraging AI and machine learning (ML) to transform innovation in drug discovery and development, announces the introduction of ChatAlphaMeld™, a game-changingInveniAI to Participate in the Truist Securities Life Sciences AI Symposium – Biotech & Tools
GUILFORD, Conn., Feb. 24, 2022 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and development, today announced that the Company will participate in the Truist Securities AI Symposium – Biotech & Tools.InveniAI and Kyowa Kirin Expand AI-Driven Partnership to a Multi-Year Strategic Collaboration for the Discovery of Novel Targets and Treatments Across Therapeutic Areas
GUILFORD, Conn. and TOKYO, Dec. 16, 2021 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and development, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE:4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology, expanded their longstanding relationship with a new, multiple drug discovery agreement. The collaboration will provide Kyowa Kiri
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding InveniAI
Sign Up For FreeTo access detailed company insights
InveniAI is a global leader in applying artificial intelligence and machine learning to accelerate drug discovery and development for diseases with unmet medical needs. Their technology platform, AlphaMeld, integrates complex scientific data to enable rapid identification and prioritization of transformative therapies. The company focuses on addres... Read More
